Insider Trading History of Caissa Capital Management Ltd.

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Caissa Capital Management Ltd. since 2023. This trader's CIK number is 1929354. At the time of last reporting, Caissa Capital Management Ltd. was the 10% Owner of Avalo Therapeutics, Inc.. (stock ticker symbol AVTX). Also see all insider trading activities at Avalo Therapeutics, Inc..


Yearly summary of insider trading at Avalo Therapeutics, Inc. (AVTX) by Caissa Capital Management Ltd.

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2023 AVTX 1,818,794 $1,658,347 0 $0 0 $0


Insider trading of Avalo Therapeutics, Inc. (AVTX) by Caissa Capital Management Ltd.

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2023-06-26 AVTX Buy 1,608,000 .63 1,016,256
2023-06-15 AVTX Buy 3,160 3.68 11,641
2023-06-16 AVTX Buy 3,000 3.90 11,715
2023-06-20 AVTX Buy 2,000 4.14 8,288
2023-06-12 AVTX Buy 2,149 4.33 9,315
2023-06-13 AVTX Buy 8,750 3.82 33,442
2023-06-14 AVTX Buy 6,000 3.48 20,874
2023-06-07 AVTX Buy 2,984 3.49 10,417
2023-06-09 AVTX Buy 5,044 4.14 20,897
2023-06-08 AVTX Buy 6,398 3.93 25,124
2023-05-31 AVTX Buy 844 2.87 2,422
2023-05-31 AVTX Buy 844 2.87 2,422
2023-05-25 AVTX Buy 2,000 2.77 5,540
2023-05-30 AVTX Buy 671 2.87 1,923
2023-05-24 AVTX Buy 9,000 2.98 26,865
2023-05-18 AVTX Buy 13,121 3.29 43,168
2023-05-19 AVTX Buy 6,500 3.52 22,854
2023-05-22 AVTX Buy 7,000 3.34 23,359
2023-05-04 AVTX Buy 15,000 2.79 41,880
2023-05-05 AVTX Buy 5,000 2.88 14,375
2023-05-08 AVTX Buy 5,000 2.62 13,110
2023-04-26 AVTX Buy 425 2.97 1,262
2023-04-25 AVTX Buy 5,571 3.00 16,707
2023-04-27 AVTX Buy 1,504 2.96 4,451
2023-04-20 AVTX Buy 5,000 3.08 15,390
2023-04-24 AVTX Buy 12,500 3.06 38,275
2023-04-17 AVTX Buy 15,000 2.96 44,430
2023-04-18 AVTX Buy 10,000 2.94 29,440
2023-04-10 AVTX Buy 31,329 2.28 71,430
2023-04-11 AVTX Buy 25,000 2.84 71,075

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Caissa Capital Management Ltd. (10% Owner of Avalo Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.